Paulness – minor correction – this is not a win-win it is a win-when. Everybody wins when there is a significant sale of synDNA ,when there is a vaccine product with the USDA, when there is a vaccine product with the NIH hiv vaccine, I could go on but I don't want to give the impression that I am a basher. lol. Point is this is a business and the programs and partnerships don’t mean as much as products and sales. Even your buyout suggestion would yield a much more favorable price if the company had clinically tested products and a sales history. There is a very simple concept here – complete some things that they have started. We don’t need any more programs, it’s time for a commercial success.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.